[go: up one dir, main page]

MX9707393A - Capsula de gelatina blanda con una cubierta de gelatina que comprende derivado de xantina. - Google Patents

Capsula de gelatina blanda con una cubierta de gelatina que comprende derivado de xantina.

Info

Publication number
MX9707393A
MX9707393A MX9707393A MX9707393A MX9707393A MX 9707393 A MX9707393 A MX 9707393A MX 9707393 A MX9707393 A MX 9707393A MX 9707393 A MX9707393 A MX 9707393A MX 9707393 A MX9707393 A MX 9707393A
Authority
MX
Mexico
Prior art keywords
xanthine derivative
shell
gelatin
soft gelatin
soft
Prior art date
Application number
MX9707393A
Other languages
English (en)
Other versions
MXPA97007393A (es
Inventor
Paul Alfred Cimiluca
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9707393A publication Critical patent/MX9707393A/es
Publication of MXPA97007393A publication Critical patent/MXPA97007393A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a composiciones farmacéuticas mejoradas que contienen un analgésico encapsulado dentro de una cubierta de gelatina blanda, en donde dicha cubierta contiene un derivado de xantina, tal como cafeína.
MXPA/A/1997/007393A 1995-03-29 1996-02-20 Capsula de gelatina blanda con una cubierta de gelatina que comprende derivado de xantina MXPA97007393A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08412627 1995-03-29
US08/412,627 US5641512A (en) 1995-03-29 1995-03-29 Soft gelatin capsule compositions
PCT/US1996/002236 WO1996029997A1 (en) 1995-03-29 1996-02-20 Soft gelatin capsule with a gelatin shell comprising xanthine derivative

Publications (2)

Publication Number Publication Date
MX9707393A true MX9707393A (es) 1997-11-29
MXPA97007393A MXPA97007393A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
CA2214399C (en) 2001-03-27
JPH11502838A (ja) 1999-03-09
AU4988596A (en) 1996-10-16
EP0817618A1 (en) 1998-01-14
CA2214399A1 (en) 1996-10-03
US5641512A (en) 1997-06-24
WO1996029997A1 (en) 1996-10-03
BR9607961A (pt) 1998-07-14

Similar Documents

Publication Publication Date Title
CA2214399A1 (en) Soft gelatin capsule with a gelatin shell comprising xanthine derivative
ES2129806T3 (es) Composiciones liquidas orales que contienen resinato de paroxetina.
ES2107235T3 (es) Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
ES2157297T3 (es) Granulos entericos de duloxetina.
BR9612258B1 (pt) inibidores de enzima conversora de interleucina-1beta, bem como composição farmacêutica.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
MX168680B (es) Metodo de solidificacion y encapsulacion que utiliza particulas de polimero de nucleo, cubierta
ES2136725T3 (es) Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo.
ES2186887T3 (es) Comprimidos que contienen una mezcla adulcorante.
TR199902175T2 (xx) Parasetamol i�eren yutma tableti.
TW360543B (en) Encapsulated pharmaceutical composition
EA200401067A1 (ru) Раствор ибупрофена для капсул с твердыми оболочками
MX24039A (es) Composiciones farmaceuticas que contienen una calcitonina como principio activo.
AR023511A1 (es) Composicion que comprende (s) y (r) 5-amino-3-ciano-1-(2,6-dicloro-4-trifluorometilfenil)-4-trifluoro-metilsulfinilpirazol, dichos compuestos aislados y usos de los mismos como plaguicida
BR0012553A (pt) Pastilhas contendo ambroxol
ES2193105T3 (es) Caramelos duros de estabilidad mejorada al almacenaje.
ES2075454T3 (es) Forma cristalina pura de rifapentina.
DE19780262D2 (de) Harpagosid-
IT8819771A0 (it) Memoria tampone ad indirizzamento pseudo virtuale.
NL191562C (nl) Dibenzo£b,d|pyranderivaten, alsmede farmaceutische preparaten die een dergelijk derivaat bevatten.
ATE296623T1 (de) Prolaktin-senkendes mittel
AR019331A2 (es) Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
DK0915087T3 (da) Sulfonamid-substituerede anellerede 5-leddede ringforbindelser, deres anvendelse som lægemiddel samt farmaceutiske præparater, som indeholder dem
ES2062782T3 (es) Capsula oleaginosa de cetoprofeno.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees